Last reviewed · How we verify
ONO-6950
At a glance
| Generic name | ONO-6950 |
|---|---|
| Sponsor | Ono Pharma USA Inc |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients (PHASE2)
- A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma (PHASE2)
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects (PHASE1)
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ONO-6950 CI brief — competitive landscape report
- ONO-6950 updates RSS · CI watch RSS
- Ono Pharma USA Inc portfolio CI